Company / EPS (Diluted)
NEPHROS INC EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$0.01
FY2025
5-year range
-$0.73 / $0.01
FY2021-FY2025
Trend
+106.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) has fluctuated over the past 9 years, ranging from $-0.73 in FY2023 to $0.01 in FY2025.
Based on SEC 10-K filings.
0.01 in FY2025.
Improved from $-0.73 to $0.01 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (diluted) increased 106.7% year-over-year.
- Lowest eps (diluted) in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -5.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.01 | +106.7% |
| FY2024 | -$0.15 | +79.5% |
| FY2023 | -$0.73 | - |
| FY2022 | - | - |
| FY2021 | -$0.52 | -15.6% |
| FY2020 | -$0.45 | +10.0% |
| FY2019 | -$0.50 | -2400.0% |
| FY2018 | -$0.02 | +66.7% |
| FY2017 | -$0.06 | +33.3% |
| FY2016 | -$0.09 | +71.0% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026